Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
205
-
Total 13F shares, excl. options
-
79.5M
-
Shares change
-
-2.98M
-
Total reported value, excl. options
-
$239M
-
Value change
-
-$5.45M
-
Put/Call ratio
-
2.52
-
Number of buys
-
116
-
Number of sells
-
-70
-
Price
-
$3.01
Significant Holders of ImmunityBio, Inc. - COM (IBRX) as of Q1 2025
255 filings reported holding IBRX - ImmunityBio, Inc. - COM as of Q1 2025.
ImmunityBio, Inc. - COM (IBRX) has 205 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 79.5M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (20.3M shares), BlackRock, Inc. (13.3M shares), STATE STREET CORP (7.58M shares), GEODE CAPITAL MANAGEMENT, LLC (4.29M shares), Woodline Partners LP (3.45M shares), CITIGROUP INC (2.71M shares), TANG CAPITAL MANAGEMENT LLC (2.33M shares), MORGAN STANLEY (1.9M shares), UBS Group AG (1.44M shares), and NORTHERN TRUST CORP (1.36M shares).
This table shows the top 205 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.